Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-04 @ 4:43 AM
Study NCT ID:
NCT00908232
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2009-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
Sponsor:
Janssen-Cilag International NV
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |